Puma Biotechnology, Inc.

PBYI

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001401667

SEC filings (opens in a new tab)

In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Puma Biotechnology, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of PBYI: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	100	1	112	+13
Shares	29.7M	1.26M	29.4M	+909.7K (+3.2%)
Value	$75.9M	$3.20M	$89.7M	+$17.0M (+23.4%)

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Puma Biotechnology, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to PBYI in Q4 2024
Institution	Shares	Value	% of portfolio
Acorn Capital Advisors, LLC	3,940,052	$12.0M	6.47%
Marshall Wace, LLP	85,580	$261.0K	0.00%
Mackenzie Financial Corp	78,653	$239.9K	0.00%
Susquehanna International Group, LLP	75,103	$229.1K	0.00%
Integrated Quantitative Investments LLC	59,866	$182.6K	0.09%
Walleye Capital LLC	38,845	$118.5K	0.00%
Cubist Systematic Strategies, LLC	32,615	$99.5K	0.00%
Prelude Capital Management, LLC	24,800	$75.6K	0.01%
Oxford Asset Management LLP	23,484	$71.6K	0.03%
Intech Investment Management LLC	20,030	$61.1K	0.00%
Bayesian Capital Management, LP	17,700	$54.0K	0.01%
C2C Wealth Management, LLC	12,000	$36.6K	0.03%
Jain Global LLC	11,871	$36.2K	0.00%
ProShare Advisors LLC	11,853	$36.2K	0.00%
Verition Fund Management LLC	10,955	$33.4K	0.00%
AQR Capital Management LLC	10,817	$33.0K	0.00%
Graham Capital Management, L.P.	10,732	$32.7K	0.00%
Gateway Wealth Partners, LLC	10,200	$31.1K	0.01%
Police & Firemen's Retirement System of New Jersey	8,322	$25.4K	0.00%
R Squared Ltd	5,020	$15.3K	0.01%
Ball & Co Wealth Management Inc.	3,506	$10.0K	0.01%
Fourth Dimension Wealth, LLC	700	$2.13K	0.00%
Caitong International Asset Management Co., Ltd	133	$406	0.00%
Aventura Private Wealth, LLC	100	$305	0.00%
SBI Securities Co., Ltd.	56	$171	0.00%
Richards, Merrill & Peterson, Inc.	40	$122	0.00%
True Wealth Design, LLC	24	$74	0.00%
IFP Advisors, Inc	14	$43	0.00%

Sold out (15)

Institutions that held Puma Biotechnology, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of PBYI in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Frazier Life Sciences Management, L.P.	3,062,558	$7.81M
Affinity Asset Advisors, LLC	250,000	$637.5K
Victory Capital Management Inc	35,097	$89.5K
ExodusPoint Capital Management, LP	30,905	$79.0K
Virtu Financial LLC	26,509	$68.0K
Buckingham Strategic Partners	19,235	$49.0K
Dynamic Technology Lab Private Ltd	17,366	$44.0K
Two Sigma Securities, LLC	12,173	$31.0K
Commonwealth Equity Services, LLC	10,790	$28.0K
Group One Trading, L.P.	4,695	$12.0K
GWM Advisors LLC	4,611	$11.8K
Aspire Private Capital, LLC	700	$1.78K
Allspring Global Investments Holdings, LLC	667	$1.70K
Jaffetilchin Investment Partners, LLC	400	$1.02K
Capital Performance Advisors LLP	15	$38

Not filed for Q4 2024 yet (1)

Institutions that held Puma Biotechnology, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PBYI in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Athyrium Capital Management, LP	1,256,411	$3.20M